Pre-Exposure Prophylaxis (PrEP)

Pre-exposure prophylaxis (PrEP) is an antiretroviral therapy-based HIV prevention strategy to prevent or at least reduce the risk of HIV infection in adults who have not been infected with the virus but are at high risk of infection.

Use of antiretroviral medication for PrEP has been approved in the European Union. As an additional prevention option it has the potential to reduce HIV transmission and contribute to reversing the increase in new infections in Europe.